CERINFUSE Trademark

Trademark Overview

On Friday, February 2, 2024, a trademark application was filed for CERINFUSE with the United States Patent and Trademark Office. The USPTO has given the CERINFUSE trademark a serial number of 98388583. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, August 4, 2025. This trademark is owned by Cerinfuse Technologies, Inc.. The CERINFUSE trademark is filed in the Medical Instrument Products category with the following description:

Implantable drug delivery ports; Medical apparatus, namely, implantable ports
cerinfuse

General Information

Serial Number98388583
Word MarkCERINFUSE
Filing DateFriday, February 2, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, August 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2024

Trademark Statements

Goods and ServicesImplantable drug delivery ports; Medical apparatus, namely, implantable ports

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, March 1, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCerinfuse Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTampa, FL 33602
Party NameCerinfuse Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33602

Trademark Events

Event DateEvent Description
Tuesday, February 6, 2024NEW APPLICATION ENTERED
Wednesday, August 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 28, 2024ASSIGNED TO EXAMINER
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 16, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, October 3, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, October 6, 2024NON-FINAL ACTION WRITTEN
Sunday, October 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, October 6, 2024NON-FINAL ACTION E-MAILED
Monday, October 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 18, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 24, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 24, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 29, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 29, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 4, 2025SOU TEAS EXTENSION RECEIVED
Monday, August 4, 2025SOU EXTENSION 1 FILED
Monday, August 4, 2025SOU EXTENSION 1 GRANTED
Tuesday, August 5, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 29, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

cerinfuse implantable ports namely apparatus medical drug delivery